Set up for pharmaceutical supply chain success amid COVID-19 and beyond

14 July 2020

In this week's Expert View, Ed Malatesta and Tim Roberts of PCI Pharma Services provide their company's perspective on supply chain readiness in the face of the global coronavirus pandemic.

The coronavirus pandemic has put many things on hold as many parts of the world are still under lockdown. Even in countries where things were beginning to open up, like in the USA, there is an uptick in cases and public health officials are concerned about a second wave.

View our Expert Report: COVID-19 and the pharmaceutical supply chainAs a leader in pharmaceutical and biopharmaceutical supply chain solutions, we are preparing for what comes next. As businesses reopen in phased approaches, and even as those approaches get delayed or are pulled back, there will inevitably be a rush to go back to the doctor, just like there will be a rush to go to salons for haircuts.

What steps can pharma and biopharma companies take from a supply chain perspective to set themselves up for success?

Think carefully about your forecast

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK